Your browser doesn't support javascript.
loading
HbA1c trajectories over 3 years in people with type 2 diabetes starting second-line glucose-lowering therapy: The prospective global DISCOVER study.
Bongaerts, Brenda; Kuss, Oliver; Bonnet, Fabrice; Chen, Hungta; Cooper, Andrew; Fenici, Peter; Gomes, Marilia B; Hammar, Niklas; Ji, Linong; Khunti, Kamlesh; Medina, Jesús; Nicolucci, Antonio; Shestakova, Marina V; Watada, Hirotaka; Rathmann, Wolfgang.
Afiliación
  • Bongaerts B; Institute of General Practice, Medical Faculty of the Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Kuss O; Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Institute for Diabetes Research at Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Bonnet F; University of Rennes, Rennes, France.
  • Chen H; AstraZeneca, Gaithersburg, Maryland, USA.
  • Cooper A; AstraZeneca, Cambridge, UK.
  • Fenici P; Catholic University of the Sacred Heart, School of Medicine and Surgery, and Biomagnetism and Clinical Physiology International Center (BACPIC), Rome, and Medical Affairs, AstraZeneca S.p.A, Milan, Italy.
  • Gomes MB; Department of Internal Medicine, Rio de Janeiro State University, Rio de Janeiro, Brazil.
  • Hammar N; Institute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden.
  • Ji L; AstraZeneca, Mölndal, Gothenburg, Sweden.
  • Khunti K; Peking University People's Hospital, Beijing, China.
  • Medina J; University of Leicester, Leicester, UK.
  • Nicolucci A; AstraZeneca, Madrid, Spain.
  • Shestakova MV; Center for Outcomes Research and Clinical Epidemiology, Pescara, Italy.
  • Watada H; Endocrinology Research Centre, Moscow, Russia.
  • Rathmann W; Department of Metabolism and Endocrinology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Diabetes Obes Metab ; 25(7): 1890-1899, 2023 07.
Article en En | MEDLINE | ID: mdl-36906837

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Hiperglucemia Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2023 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Hiperglucemia Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2023 Tipo del documento: Article País de afiliación: Alemania